Want to become a UF Patient Advocate?

  pic1
Have you experienced a diagnosis of a Neuroendocrine Tumour (NET) – either as a patient, carer or family member?
Are you passionate about improving outcomes for people with NETs?

Are you keen to share your experiences and expertise to influence the development of resources and services provided to communities affected by NETs?
The Unicorn Foundation invites you to consider nominating for a position on our new Consumer Advisory Group (CAG).
This volunteer group will be meeting bi-monthly via teleconference, with the possibility of gaining funding for an annual face to face meeting. The CAG will function as a consumer representative voice for people who have been diagnosed with NETs, and their carers. By working together, the CAG will provide a mechanism for the consumer voice to be addressed, with the overall goal of providing better services and outcomes for people and communities affected by NETs.
We are looking for approximately eight to ten Consumer Advisory Members, with a mixture of patients and carers. Ideally representation will be from a wide range of states and territories (from both regional and metropolitan areas), with a mix of gender, age and ethnicity. Ideally there will also be representation from Aboriginal and Torres Strait Islander heritage.
People who would like to nominate will be asked to provide a written application, addressing key selection criteria. There will be an interview process (via telephone) and all applicants need to be willing to undergo a police and working with children check.

Relevant training will also be provided.

For more information, please see the terms of reference and key selection documents. If you would like to discuss your potential involvement in this group, or have further questions, please email netnurse@neuroendocrine.org.au.

Deadline for expressions of interest March 9 2016

CAG – Key Selection Criteria

https://neuroendocrine.org.au/wp-content/uploads/2020/03/CAG-Key-Selection-Criteria.pdf 

CAG – Terms of Reference

https://neuroendocrine.org.au/wp-content/uploads/2020/03/CAG-Terms-of-reference.pdf

Share this article

Subscribe to our Newsletter

Stay up to date on news and events, clinical trials and new research on neuroendocrine cancers.

Related News

INCA Annual Summit 2026

2026 ACNNP and CPSP Collaboration Forum

NECA welcomes PBS listing of Selpercatinib for medullary thyroid cancer

Vote now: NeuroEndocrine Cancer Australia is entered in SIX Patients Australia Awards!

Neuroendocrine Cancer Day

Neuroendocrine Cancer Day is on 10 November, and every bit of support counts.

Create an event, share your artwork, or donate on our ‘Double Your Impact’ days. There are so many ways to stand with the NET community.